Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Recurrent Multiple Myeloma Clinical Trials

3 recruiting trials for Recurrent Multiple Myeloma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGPhase 1 / Phase 2NCT07181941

Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class...

This phase I/II trial evaluates the safety and feasibility of early, response-based dose reduction of linvoseltamab in the treatment of patients multiple myeloma that has come...

Sponsor: Fred Hutchinson Cancer CenterEnrolling: 301 location
RECRUITINGPhase 1NCT06622005

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or...

This phase I trial tests the safety and side effects of SX-682 in combination with standard of care treatment carfilzomib, daratumumab-hyaluronidase, and dexamethasone in treating...

Sponsor: Roswell Park Cancer InstituteEnrolling: 151 location
RECRUITINGPhase 1 / Phase 2NCT06232044

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory...

This phase I/II trial tests the safety, side effects, best dose, and effectiveness of iberdomide in combination with belantamab mafodotin and dexamethasone in treating patients...

Sponsor: Alliance for Clinical Trials in OncologyEnrolling: 8820 locations